COR240719P230000
- 6.80
- 0.000.00%
Cencora Newsroom
McKesson, Cardinal, Cencora Interested in Buying Private Cancer Clinics - Report
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 8.06% on an annualized basis producing an average annual return of 21.25%. Currently, Cencora has a market capitalization of $44
Why Cencora (COR) Is a Top Value Stock for the Long-Term
Why Cencora (COR) Is Poised to Beat Earnings Estimates Again
Investing in Cencora (NYSE:COR) Five Years Ago Would Have Delivered You a 179% Gain
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 6.78% on an annualized basis producing an average annual return of 19.86%. Currently, Cencora has a market capitalization of $43
A Closer Look at 4 Analyst Recommendations For Cencora
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Cencora (NYSE:COR) in the last three months.The table below provides a snapshot of their
Baird Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $285
Baird analyst Dave Rodgers maintains $Cencora(COR.US)$ with a buy rating, and adjusts the target price from $280 to $285.According to TipRanks data, the analyst has a success rate of 51.3% and a
Express News | Baird Maintains Outperform on Cencora, Raises Price Target to $285
Express News | Cencora Inc : TD Cowen Raises Target Price to $271 From $265
Express News | Cencora Inc : Baird Raises Target Price to $285 From $280
Express News | Outlook Therapeutics® Announces UK Mhra Marketing Authorization of Lytenava™ (Bevacizumab Gamma) for the Treatment of Wet AMD
Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
(COR) - Analyzing Cencora's Short Interest
Cencora's (NYSE:COR) short percent of float has risen 7.85% since its last report. The company recently reported that it has 9.40 million shares sold short, which is 6.46% of all regular shares that a
These 4 Measures Indicate That Cencora (NYSE:COR) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when
Earnings Scorecard: Nike Loses Air After Shocker Results Send Shares Sliding
BofA Securities Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $256
BofA Securities analyst Allen Lutz maintains $Cencora(COR.US)$ with a buy rating, and maintains the target price at $256.According to TipRanks data, the analyst has a success rate of 54.2% and a total
Top Gap Ups and Downs on Thursday: MU, SONY, ZTS and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Express News | Cencora Shares Are Trading Lower After Walgreens Lowered Its Outlook and Announced Store Closure
Cencora Is Maintained at Outperform by Leerink Partners
Cencora Is Maintained at Outperform by Leerink Partners